- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy of biologics in atopic dermatitis
Authors
Keywords
-
Journal
EXPERT OPINION ON BIOLOGICAL THERAPY
Volume -, Issue -, Pages 1-14
Publisher
Informa UK Limited
Online
2020-01-31
DOI
10.1080/14712598.2020.1722998
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy and safety of dupilumab monotherapy in adults with moderate-to-severe atopic dermatitis: A pooled analysis of two phase 3 randomized trials (LIBERTY AD SOLO 1 and SOLO 2)
- (2019) Diamant Thaçi et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- GBR 830, an anti-OX40, improves skin gene signatures and clinical scores in patients with atopic dermatitis
- (2019) Emma Guttman-Yassky et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Age-specific changes in the molecular phenotype of patients with moderate-to-severe atopic dermatitis
- (2019) Lisa Zhou et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Understanding the Immune Landscape in Atopic Dermatitis: The Era of Biologics and Emerging Therapeutic Approaches
- (2019) Matthew Moyle et al. EXPERIMENTAL DERMATOLOGY
- The oral Janus kinase/spleen tyrosine kinase inhibitor ASN 002 demonstrates efficacy and improves associated systemic inflammation in patients with moderate‐to‐severe atopic dermatitis: results from a randomized double‐blind placebo‐controlled study
- (2019) R. Bissonnette et al. BRITISH JOURNAL OF DERMATOLOGY
- Eczematous eruption during anti‐interleukin 17 treatment of psoriasis: an emerging condition
- (2019) M. Napolitano et al. BRITISH JOURNAL OF DERMATOLOGY
- Conjunctivitis in dupilumab clinical trials
- (2019) B. Akinlade et al. BRITISH JOURNAL OF DERMATOLOGY
- What’s New in Atopic Dermatitis
- (2019) Yael Renert-Yuval et al. DERMATOLOGIC CLINICS
- Risankizumab: First Global Approval
- (2019) Kate McKeage et al. DRUGS
- The blood proteomic signature of early-onset pediatric atopic dermatitis shows systemic inflammation and is distinct from adult, longstanding disease
- (2019) Patrick M. Brunner et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Conjunctivitis in atopic dermatitis patients with and without dupilumab therapy – international eczema council survey and opinion
- (2019) J.P. Thyssen et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Oral JAK/SYK-inhibition (ASN002) suppresses inflammation and improves epidermal barrier markers in atopic dermatitis
- (2019) Ana B. Pavel et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Efficacy and Safety of Mepolizumab Administered Subcutaneously for Moderate to Severe Atopic Dermatitis
- (2019) Eunhye G. Kang et al. ALLERGY
- Phase 2B randomized study of nemolizumab in adults with moderate-to-severe atopic dermatitis and severe pruritus
- (2019) Jonathan I. Silverberg et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Occurrence of psoriasiform eruption during dupilumab therapy for adult atopic dermatitis: A case series
- (2019) Maddalena Napolitano et al. Dermatologic Therapy
- Upadacitinib in Adults With Moderate-to-Severe Atopic Dermatitis: 16-Week Results From a Randomized, Placebo-Controlled Trial
- (2019) Emma Guttman-Yassky et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Evolution of pathologic T-cell subsets in atopic dermatitis from infancy to adulthood
- (2019) Tali Czarnowicki et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Real-life experience on effectiveness and safety of dupilumab in adult patients with moderate-to-severe atopic dermatitis
- (2019) M. C. Fargnoli et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- Proof-of-concept clinical trial of etokimab shows a key role for IL-33 in atopic dermatitis pathogenesis
- (2019) Yi-Ling Chen et al. Science Translational Medicine
- Efficacy and Safety of Dupilumab in Adolescents With Uncontrolled Moderate to Severe Atopic Dermatitis
- (2019) Eric L. Simpson et al. JAMA Dermatology
- New treatments for atopic dermatitis targeting beyond IL-4/IL-13 cytokines
- (2019) Yael Renert-Yuval et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Dupilumab: A Review in Moderate-to-Severe Atopic Dermatitis
- (2018) James E. Frampton et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- Immunologic, microbial, and epithelial interactions in atopic dermatitis
- (2018) Patrick M. Brunner et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo-controlled, randomized phase III clinical t
- (2018) M. de Bruin-Weller et al. BRITISH JOURNAL OF DERMATOLOGY
- Epidemiology of Adult Atopic Dermatitis
- (2018) Ryan Sacotte et al. CLINICS IN DERMATOLOGY
- Atopic dermatitis in diverse racial and ethnic groups-Variations in epidemiology, genetics, clinical presentation and treatment
- (2018) Bridget P. Kaufman et al. EXPERIMENTAL DERMATOLOGY
- Atopic dermatitis in Chinese patients shows T H 2/T H 17-skewing with psoriasiform features
- (2018) Tom C. Chan et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Early-onset pediatric atopic dermatitis is characterized by T H 2/T H 17/T H 22-centered inflammation and lipid alterations
- (2018) Patrick M. Brunner et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Serum from Asian patients with atopic dermatitis is characterized by T H 2/T H 22 activation, which is highly correlated with nonlesional skin measures
- (2018) Huei-Chi Wen et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Treatment of atopic dermatitis with tralokinumab, an anti–IL-13 mAb
- (2018) Andreas Wollenberg et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- IL-17C: A Unique Epithelial Cytokine with Potential for Targeting across the Spectrum of Atopic Dermatitis and Psoriasis
- (2018) Emma Guttman-Yassky et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Neutralization of IL-17C Reduces Skin Inflammation in Mouse Models of Psoriasis and Atopic Dermatitis
- (2018) Nick Vandeghinste et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Baricitinib in adult patients with moderate-to-severe atopic dermatitis: a phase 2 parallel, double-blinded, randomized placebo-controlled multiple-dose study
- (2018) Emma Guttman-Yassky et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- A systematic review and meta-analysis of the prevalence and phenotype of adult-onset atopic dermatitis
- (2018) Harrison H. Lee et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- T-cell inhibitors for atopic dermatitis
- (2018) W. James Tidwell et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Efficacy and safety of fezakinumab (an IL-22 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by conventional treatments: A randomized, double-blind, phase 2a trial
- (2018) Emma Guttman-Yassky et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Efficacy and safety of lebrikizumab (an anti-IL-13 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical corticosteroids: A randomized, placebo-controlled phase II trial (TREBLE)
- (2018) Eric L. Simpson et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Dual neutralization of both interleukin 17A and interleukin 17F with bimekizumab in patients with psoriasis: Results from BE ABLE 1, a 12-week randomized, double-blinded, placebo-controlled phase 2b trial
- (2018) Kim A. Papp et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Conjunctivitis occurring in atopic dermatitis patients treated with dupilumab-clinical characteristics and treatment
- (2018) Andreas Wollenberg et al. Journal of Allergy and Clinical Immunology-In Practice
- Atopic dermatitis in African American patients is TH2/TH22-skewed with TH1/TH17 attenuation
- (2018) Riana D. Sanyal et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Dupilumab progressively improves systemic and cutaneous abnormalities in atopic dermatitis patients
- (2018) Emma Guttman-Yassky et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Baseline IL-22 expression in patients with atopic dermatitis stratifies tissue responses to fezakinumab
- (2018) Patrick M. Brunner et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- JAK Inhibitors for Atopic Dermatitis: An Update
- (2018) Helen He et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- Distinct transcriptomic profiles of early-onset atopic dermatitis in blood and skin of pediatric patients
- (2018) Patrick M. Brunner et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Tezepelumab, an anti-TSLP monoclonal antibody, in the treatment of moderate to severe atopic dermatitis: A randomized phase 2a clinical trial
- (2018) Eric L. Simpson et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Anti-IL-33 Antibody Has a Therapeutic Effect in an Atopic Dermatitis Murine Model Induced by 2, 4-Dinitrochlorobenzene
- (2017) Ge Peng et al. INFLAMMATION
- Efficacy and safety of dupilumab for the treatment of adult atopic dermatitis: A meta-analysis of randomized clinical trials
- (2017) Yue Han et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Molecular signatures order the potency of topically applied anti-inflammatory drugs in patients with atopic dermatitis
- (2017) Emma Guttman-Yassky et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Novel concepts of prevention and treatment of atopic dermatitis through barrier and immune manipulations with implications for the atopic march
- (2017) Tali Czarnowicki et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- The immunology of atopic dermatitis and its reversibility with broad-spectrum and targeted therapies
- (2017) Patrick M. Brunner et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Major differences between human atopic dermatitis and murine models, as determined by using global transcriptomic profiling
- (2017) David A. Ewald et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Atopic Dermatitis in Adults: A Diagnostic Challenge
- (2017) JF Silvestre Salvador et al. JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY
- Increasing Comorbidities Suggest that Atopic Dermatitis Is a Systemic Disorder
- (2017) Patrick M. Brunner et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- An Integrated Model of Atopic Dermatitis Biomarkers Highlights the Systemic Nature of the Disease
- (2017) Benjamin Ungar et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Structural Characterisation Reveals Mechanism of IL-13-Neutralising Monoclonal Antibody Tralokinumab as Inhibition of Binding to IL-13Rα1 and IL-13Rα2
- (2017) B. Popovic et al. JOURNAL OF MOLECULAR BIOLOGY
- When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema Council
- (2017) Eric L. Simpson et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial
- (2017) Andrew Blauvelt et al. LANCET
- The atopic dermatitis blood signature is characterized by increases in inflammatory and cardiovascular risk proteins
- (2017) Patrick M. Brunner et al. Scientific Reports
- The ‘omics’ revolution
- (2016) Margeaux Oliva et al. Current Opinion in Allergy and Clinical Immunology
- Efficacy and safety of ustekinumab treatment in adults with moderate-to-severe atopic dermatitis
- (2016) Saakshi Khattri et al. EXPERIMENTAL DERMATOLOGY
- Efficacy of omalizumab in patients with atopic dermatitis: A systematic review and meta-analysis
- (2016) Hsiao-Han Wang et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Early-onset pediatric atopic dermatitis is T H 2 but also T H 17 polarized in skin
- (2016) Hitokazu Esaki et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- A mild topical steroid leads to progressive anti-inflammatory effects in the skin of patients with moderate-to-severe atopic dermatitis
- (2016) Patrick M. Brunner et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- 372 The effect of dupilumab on biomarkers in a randomized phase 2b clinical trial in adults with moderate-to-severe atopic dermatitis
- (2016) J. Hamilton et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Atopic dermatitis
- (2016) Stephan Weidinger et al. LANCET
- Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
- (2016) Eric L. Simpson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Drug evaluation review: dupilumab in atopic dermatitis
- (2015) Jennifer D Hamilton et al. Immunotherapy
- Skin-homing and systemic T-cell subsets show higher activation in atopic dermatitis versus psoriasis
- (2015) Tali Czarnowicki et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- IL-33 impacts on the skin barrier by downregulating the expression of filaggrin
- (2015) Jenny Seltmann et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Alopecia areata profiling shows TH1, TH2, and IL-23 cytokine activation without parallel TH17/TH22 skewing
- (2015) Mayte Suárez-Fariñas et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- RNA sequencing atopic dermatitis transcriptome profiling provides insights into novel disease mechanisms with potential therapeutic implications
- (2015) Mayte Suárez-Fariñas et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- The Asian atopic dermatitis phenotype combines features of atopic dermatitis and psoriasis with increased TH17 polarization
- (2015) Shinji Noda et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Identification of novel immune and barrier genes in atopic dermatitis by means of laser capture microdissection
- (2015) Hitokazu Esaki et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- The immunogenetics of Psoriasis: A comprehensive review
- (2015) Jamie L. Harden et al. JOURNAL OF AUTOIMMUNITY
- Cyclosporine in patients with atopic dermatitis modulates activated inflammatory pathways and reverses epidermal pathology
- (2014) Saakshi Khattri et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Dupilumab improves the molecular signature in skin of patients with moderate-to-severe atopic dermatitis
- (2014) Jennifer D. Hamilton et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Dissecting childhood asthma with nasal transcriptomics distinguishes subphenotypes of disease
- (2014) Alex Poole et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Distribution of IL-31 and its receptor expressing cells in skin of atopic dermatitis
- (2014) Atsuhiko Kato et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Guidelines of care for the management of atopic dermatitis
- (2014) Robert Sidbury et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis
- (2014) Lisa A. Beck et al. NEW ENGLAND JOURNAL OF MEDICINE
- Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials
- (2014) Richard G. Langley et al. NEW ENGLAND JOURNAL OF MEDICINE
- Developmental Profiles of Eczema, Wheeze, and Rhinitis: Two Population-Based Birth Cohort Studies
- (2014) Danielle C. M. Belgrave et al. PLOS MEDICINE
- IL-33 Promotes the Induction and Maintenance of Th2 Immune Responses by Enhancing the Function of OX40 Ligand
- (2014) Naoko Murakami-Satsutani et al. ALLERGOLOGY INTERNATIONAL
- Periostin in Allergic Inflammation
- (2014) Kenji Izuhara et al. ALLERGOLOGY INTERNATIONAL
- Atopic dermatitis and the atopic march revisited
- (2013) S. C. Dharmage et al. ALLERGY
- Periostin, a novel biomarker of TH2-driven asthma
- (2013) Amit D. Parulekar et al. CURRENT OPINION IN PULMONARY MEDICINE
- IL-17 family: Cytokines, receptors and signaling
- (2013) Chunfang Gu et al. CYTOKINE
- Role of Interleukin 1 in Atopic Dermatitis
- (2013) William Abramovits et al. DERMATOLOGIC CLINICS
- Intrinsic atopic dermatitis shows similar TH2 and higher TH17 immune activation compared with extrinsic atopic dermatitis
- (2013) Mayte Suárez-Fariñas et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- A sensory neuron–expressed IL-31 receptor mediates T helper cell–dependent itch: Involvement of TRPV1 and TRPA1
- (2013) Ferda Cevikbas et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Structural Basis of Signaling Blockade by Anti-IL-13 Antibody Lebrikizumab
- (2013) Mark Ultsch et al. JOURNAL OF MOLECULAR BIOLOGY
- Increased frequencies of IL-31-producing T cells are found in chronic atopic dermatitis skin
- (2012) Krisztina Szegedi et al. EXPERIMENTAL DERMATOLOGY
- Langerhans cells are critical in epicutaneous sensitization with protein antigen via thymic stromal lymphopoietin receptor signaling
- (2012) Saeko Nakajima et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Progressive activation of TH2/TH22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis
- (2012) Julia K. Gittler et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- IL-33 and ST2 in Atopic Dermatitis: Expression Profiles and Modulation by Triggering Factors
- (2012) Terhi Savinko et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- IL-36R ligands are potent regulators of dendritic and T cells
- (2011) S. Vigne et al. BLOOD
- Interleukin-22 downregulates filaggrin expression and affects expression of profilaggrin processing enzymes
- (2011) D. Gutowska-Owsiak et al. BRITISH JOURNAL OF DERMATOLOGY
- IgE, Mast Cells, and Eosinophils in Atopic Dermatitis
- (2011) Fu-Tong Liu et al. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
- Interleukin-17C Promotes Th17 Cell Responses and Autoimmune Disease via Interleukin-17 Receptor E
- (2011) Seon Hee Chang et al. IMMUNITY
- Reversal of atopic dermatitis with narrow-band UVB phototherapy and biomarkers for therapeutic response
- (2011) Suzanne Tintle et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Contrasting pathogenesis of atopic dermatitis and psoriasis—Part I: Clinical and pathologic concepts
- (2011) Emma Guttman-Yassky et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- IL-13 Induces Skin Fibrosis in Atopic Dermatitis by Thymic Stromal Lymphopoietin
- (2011) M.-H. Oh et al. JOURNAL OF IMMUNOLOGY
- Role of IL-33 in inflammation and disease
- (2011) Ashley M Miller Journal of Inflammation-London
- IL-17RE is the functional receptor for IL-17C and mediates mucosal immunity to infection with intestinal pathogens
- (2011) Xinyang Song et al. NATURE IMMUNOLOGY
- IL-17C regulates the innate immune function of epithelial cells in an autocrine manner
- (2011) Vladimir Ramirez-Carrozzi et al. NATURE IMMUNOLOGY
- Atopic Dermatitis
- (2010) Thomas Bieber Annals of Dermatology
- Genetic variants in thymic stromal lymphopoietin are associated with atopic dermatitis and eczema herpeticum
- (2010) Pei-Song Gao et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Eczema Prevalence in the United States: Data from the 2003 National Survey of Children's Health
- (2010) Tatyana E. Shaw et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Cytokine modulation of atopic dermatitis filaggrin skin expression
- (2009) Michael D. Howell et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three
- (2009) Joseph A. Odhiambo et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- IL-22–producing “T22” T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17–producing TH17 T cells
- (2009) Kristine E. Nograles et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Differential requirement for the activation of the inflammasome for processing and release of IL-1 in monocytes and macrophages
- (2008) M. G. Netea et al. BLOOD
- Loricrin and involucrin expression is down-regulated by Th2 cytokines through STAT-6
- (2008) Byung Eui Kim et al. CLINICAL IMMUNOLOGY
- Anti-interleukin-31-antibodies ameliorate scratching behaviour in NC/Nga mice: a model of atopic dermatitis
- (2008) Øystein Grimstad et al. EXPERIMENTAL DERMATOLOGY
- Transgenic Expression of Interleukin-13 in the Skin Induces a Pruritic Dermatitis and Skin Remodeling
- (2008) Tao Zheng et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)
- (2008) Kim A Papp et al. LANCET
- TSLP acts on infiltrating effector T cells to drive allergic skin inflammation
- (2008) R. He et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search